RASSF2 and acute myeloid leukemia: This transcriptional repression has downstream functional consequences to t(8;21)-associated leukemogenesis, as RASSF2 knockdown in a non-t(8;21) AML context is sufficient to reproduce an established RUNX1-ETO gene expression signature.